Targeted pharmacogenomic sequencing of antimalarial drug-metabolism genes
Targeted amplicon sequencing of human pharmacogenomic genes involved in antimalarial drug metabolism, including CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP3A4, CYP3A5 and NAT2, using Illumina paired-end sequencing.